185 assets in Pancreatic Adenocarcinoma

Therapeutic assets addressing Pancreatic Adenocarcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Xer-001 Pancreatic Adenocarcinoma	Xerient Pharma	P1/2	CC (45)
xnw27011 Pancreatic Adenocarcinoma	Evopoint Biosciences Inc.	P1/2	CC (45)
Nelitolimod Pancreatic Adenocarcinoma	TriSalus Life Sciences, Inc.	P1	CC (44)
Allogeneic Natural Killer Cells Pancreatic Adenocarcinoma	Medigen Biotechnology Corporation	P1/2	CC (43)
Apl-5125 Pancreatic Adenocarcinoma	Apollo Therapeutics Ltd	P1/2	CC (43)
asp546c Pancreatic Adenocarcinoma	Astellas Pharma Global Development, Inc.	P1/2	CC (43)
Bms-936558-01 Pancreatic Adenocarcinoma	Bristol-Myers Squibb	P1/2	CC (43)
Cholestyramine Pancreatic Adenocarcinoma	City of Hope Medical Center	P1	CC (43)
ct-95 Pancreatic Adenocarcinoma	Context Therapeutics Inc.	P1	CC (43)
Decoy20 Pancreatic Adenocarcinoma	Indaptus Therapeutics, Inc	P1/2	CC (43)
Elimusertib Pancreatic Adenocarcinoma	National Cancer Institute (NCI)	P1	CC (43)
Gtaexs617 Pancreatic Adenocarcinoma	Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.	P1/2	CC (43)
Hafnium Oxide Pancreatic Adenocarcinoma	M.D. Anderson Cancer Center	P1	CC (43)
(-)-Hydroxyurea Methylacylfulvene Pancreatic Adenocarcinoma	Lantern Pharma Inc.	P1/2	CC (43)
Imm-1-104 Pancreatic Adenocarcinoma	Immuneering Corporation	P1/2	CC (43)
jk08 Pancreatic Adenocarcinoma	Salubris Biotherapeutics Inc	P1/2	CC (43)
Leflunomide Pancreatic Adenocarcinoma	City of Hope Medical Center	P1	CC (43)
Minnelide Pancreatic Adenocarcinoma	Minneamrita Therapeutics LLC	P1	CC (43)
Panitumumab-Irdye800 Pancreatic Adenocarcinoma	George Poultsides	P1/2	CC (43)
Ptm-101 Pancreatic Adenocarcinoma	PanTher Therapeutics	P1	CC (43)
Pumitamig Pancreatic Adenocarcinoma	Bristol-Myers Squibb	P1/2	CC (43)
Pyrvinium Pancreatic Adenocarcinoma	Thomas Jefferson University	P1	CC (43)
Sigvotatug Vedotin Pancreatic Adenocarcinoma	Seagen, a wholly owned subsidiary of Pfizer	P1	CC (43)
tc-510 Pancreatic Adenocarcinoma	TCR2 Therapeutics	P1/2	CC (43)
The-0504 Pancreatic Adenocarcinoma	Thena Biotech S.r.l.	P1	CC (43)
Tivozanib Pancreatic Adenocarcinoma	University of Florida	P1/2	CC (43)
XYA02 Pancreatic Adenocarcinoma	XYone Therapeutics, Inc	P1/2	CC (43)
zm008 Pancreatic Adenocarcinoma	Zumutor Biologics Inc.	P1	CC (43)
Aquocobalamin Pancreatic Adenocarcinoma	General Oncology, Inc.	P1	CC (41)
Balstilimab Pancreatic Adenocarcinoma	HonorHealth Research Institute	P1	CC (41)
Botensilimab Pancreatic Adenocarcinoma	HonorHealth Research Institute	P1	CC (41)
Calaspargase Pegol Pancreatic Adenocarcinoma	OHSU Knight Cancer Institute	P1	CC (41)
Camustine Pancreatic Adenocarcinoma	General Oncology, Inc.	P1	CC (41)
Celecoxib Pancreatic Adenocarcinoma	HonorHealth Research Institute	P1	CC (41)
Chloroquine Pancreatic Adenocarcinoma	HonorHealth Research Institute	P1	CC (41)
Copper Cu 64-Dota-A2Dm Pancreatic Adenocarcinoma	City of Hope Medical Center	P1	CC (41)
Darleukin Pancreatic Adenocarcinoma	Philogen S.p.A.	P1	CC (41)
Falimarev Pancreatic Adenocarcinoma	National Cancer Institute (NCI)	P1	CC (41)
Guadecitabine Pancreatic Adenocarcinoma	University of Southern California	P1	CC (41)
Hdac Inhibitor Cxd101 Pancreatic Adenocarcinoma	ImmunityBio, Inc.	P1	CC (41)
Inalimarev Pancreatic Adenocarcinoma	National Cancer Institute (NCI)	P1	CC (41)
Ligritinib Pancreatic Adenocarcinoma	Jonsson Comprehensive Cancer Center	P1	CC (41)
Melphalan Pancreatic Adenocarcinoma	General Oncology, Inc.	P1	CC (41)
nh002 injectable suspension Pancreatic Adenocarcinoma	National Taiwan University Hospital	P1	CC (41)
Nogitecan Pancreatic Adenocarcinoma	National Cancer Institute (NCI)	P1	CC (41)
Ruxolitinib Pancreatic Adenocarcinoma	Philogen S.p.A.	P1	CC (41)
Sotevtamab Pancreatic Adenocarcinoma	ImmunityBio, Inc.	P1	CC (41)
tcr1020-cd8 t cells Pancreatic Adenocarcinoma	University of Pennsylvania	P1	CC (41)
tr-002 Pancreatic Adenocarcinoma	University of California, Davis	P1	CC (41)
Recombinant Ephb4-Hsa Fusion Protein Pancreatic Adenocarcinoma	University of Southern California	P1	CC (40)

Showing 101 to 150 of 185 assets

PreviousPage 3 of 4Next